搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella paratyphi C 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (menH) CSB-YP505730SWU
CSB-EP505730SWU
CSB-BP505730SWU
CSB-MP505730SWU
CSB-EP505730SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB) CSB-YP505731SWU
CSB-EP505731SWU
CSB-BP505731SWU
CSB-MP505731SWU
CSB-EP505731SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 50S ribosomal protein L16 (rplP) CSB-YP505732SWU
CSB-EP505732SWU
CSB-BP505732SWU
CSB-MP505732SWU
CSB-EP505732SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 30S ribosomal protein S7 (rpsG) CSB-YP505733SWU
CSB-EP505733SWU
CSB-BP505733SWU
CSB-MP505733SWU
CSB-EP505733SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Protein slyX (slyX) CSB-YP505734SWU
CSB-EP505734SWU
CSB-BP505734SWU
CSB-MP505734SWU
CSB-EP505734SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Siroheme synthase (cysG) CSB-YP505735SWU
CSB-EP505735SWU
CSB-BP505735SWU
CSB-MP505735SWU
CSB-EP505735SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Periplasmic nitrate reductase (napA), partial CSB-YP505736SWU
CSB-EP505736SWU
CSB-BP505736SWU
CSB-MP505736SWU
CSB-EP505736SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Elongation factor P-like protein (yeiP) CSB-YP505737SWU
CSB-EP505737SWU
CSB-BP505737SWU
CSB-MP505737SWU
CSB-EP505737SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C UPF0226 membrane protein SPC_3650 (SPC_3650), partial CSB-YP505738SWU
CSB-EP505738SWU
CSB-BP505738SWU
CSB-MP505738SWU
CSB-EP505738SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Cytoplasmic trehalase (treF), partial CSB-YP505739SWU
CSB-EP505739SWU
CSB-BP505739SWU
CSB-MP505739SWU
CSB-EP505739SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Multidrug resistance protein MdtB (mdtB), partial CSB-YP505740SWU
CSB-EP505740SWU
CSB-BP505740SWU
CSB-MP505740SWU
CSB-EP505740SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Histidinol-phosphate aminotransferase (hisC) CSB-YP505741SWU
CSB-EP505741SWU
CSB-BP505741SWU
CSB-MP505741SWU
CSB-EP505741SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (cobT) CSB-YP505742SWU
CSB-EP505742SWU
CSB-BP505742SWU
CSB-MP505742SWU
CSB-EP505742SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP505743SWU
CSB-EP505743SWU
CSB-BP505743SWU
CSB-MP505743SWU
CSB-EP505743SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Orotate phosphoribosyltransferase (pyrE) CSB-YP505744SWU
CSB-EP505744SWU
CSB-BP505744SWU
CSB-MP505744SWU
CSB-EP505744SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Purine ribonucleoside efflux pump nepI (nepI), partial CSB-YP505745SWU
CSB-EP505745SWU
CSB-BP505745SWU
CSB-MP505745SWU
CSB-EP505745SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C D-serine dehydratase (dsdA) CSB-YP505746SWU
CSB-EP505746SWU
CSB-BP505746SWU
CSB-MP505746SWU
CSB-EP505746SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP505747SWU
CSB-EP505747SWU
CSB-BP505747SWU
CSB-MP505747SWU
CSB-EP505747SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C ATP synthase epsilon chain (atpC) CSB-YP505748SWU
CSB-EP505748SWU
CSB-BP505748SWU
CSB-MP505748SWU
CSB-EP505748SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C ATP synthase gamma chain (atpG) CSB-YP505749SWU
CSB-EP505749SWU
CSB-BP505749SWU
CSB-MP505749SWU
CSB-EP505749SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>